CCEL 8-K 2026-09-14
CRYO CELL INTERNATIONAL INC (CCEL) 8-K dated 2026-09-14 — accession 0001193125-26-390647.
CRYO CELL INTERNATIONAL INC (CCEL) is a medical care facilities company listed on US.
CRYO CELL INTERNATIONAL INC filed a 8-K on 2026-09-14. Accession 0001193125-26-390647.
This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported CCEL revenue for 2025-11-30 was $31.6M. Net income was -$2.4M. Revenue was down 1.3% from 2024-11-30 to 2025-11-30. CCEL currently screens at market cap $39.6M.
Not investment advice. The CCEL SEC hub lists recent forms. The stock page is the research view.